Bide Pharmatech Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Long Dai
Chief executive officer
CN¥738.4k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.7yrs |
| CEO ownership | 14.4% |
| Management average tenure | no data |
| Board average tenure | 3.7yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | CN¥99m |
| Dec 31 2023 | n/a | n/a | CN¥110m |
| Sep 30 2023 | n/a | n/a | CN¥161m |
| Jun 30 2023 | n/a | n/a | CN¥171m |
| Mar 31 2023 | n/a | n/a | CN¥157m |
| Dec 31 2022 | CN¥738k | n/a | CN¥146m |
| Sep 30 2022 | n/a | n/a | CN¥129m |
| Jun 30 2022 | n/a | n/a | CN¥114m |
| Mar 31 2022 | n/a | n/a | CN¥101m |
| Dec 31 2021 | n/a | n/a | CN¥98m |
| Dec 31 2020 | CN¥910k | CN¥910k | CN¥59m |
Compensation vs Market: Long's total compensation ($USD101.60K) is about average for companies of similar size in the CN market ($USD117.30K).
Compensation vs Earnings: Long's compensation has been consistent with company performance over the past year.
CEO
Long Dai (50 yo)
3.7yrs
Tenure
CN¥738,400
Compensation
Mr. Long Dai is General Manager & Chairman of the Board of Bide Pharmatech Co., Ltd. from October 17, 2020.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| General Manager & Chairman of the Board | 3.7yrs | CN¥738.40k | 14.42% CN¥ 397.1m | |
| Deputy GM & Director | 3.7yrs | CN¥858.40k | no data | |
| Director | 3.7yrs | no data | 32.61% CN¥ 898.1m | |
| Independent Director | 3.3yrs | CN¥60.00k | no data | |
| Independent Director | 3.3yrs | no data | no data |
3.7yrs
Average Tenure
52yo
Average Age
Experienced Board: 688073's board of directors are considered experienced (3.7 years average tenure).